The Protective Effects of Pyridoxine on Linezolid-Induced Hematological Toxicity, Hepatotoxicity, and Oxidative Stress in Rats
Authors:
Open Access
- 2 May 2023
- journal article
- research article
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 58 (3) , 298-301
Abstract
Objective: Linezolid is often used to treat antibacterial-resistant infections. Linezolid can cause side effects. To date, the effectiveness of the simultaneous administration of pyridoxine and linezolid is unclear. Here we investigate the protective effect of pyridoxine on linezolid-induced hematological toxicity, hepatotoxicity, and oxidative stress in rats. Material and Methods: The 40 male pediatric Spraque–Dawley rats were separated into 4 groups: control, linezolid, pyridoxine, and linezolid–pyridoxine. A complete blood count, liver function test, and measurements of antioxidant enzyme activities for superoxide dismutase, glutathione peroxidase, catalase, and lipid peroxidation were performed in blood before treatment and 2 weeks after administration of the treatment. Results: White blood cell and hemoglobin counts for the linezolid group decreased, and the alanine aminotransferase level in the linezolid group increased compared to their respective baseline values. Post-treatment white blood cell decreased in the linezolid and linezolid– pyridoxine groups compared to those in the control group (P < .001). Alanine aminotransferase levels increased in the linezolid and linezolid–pyridoxine groups compared to those in the control group (P < .001 and P < .05, respectively). The activity of superoxide dismutase, catalase, glutathione peroxidase, and malondialdehyde levels increased in the linezolid group compared to the control group (P < .001, P < .05, P < .001, and P < .001, respectively). Linezolid plus pyridoxine treatment caused a significant decrease in malondialdehyde levels and superoxide dismutase, catalase, and glutathione peroxidase enzyme activities compared to the linezolid group (P < .001, P < .01, P < .001, and P < .01, respectively). Conclusion: Pyridoxine may be an effective adjuvant agent for the prevention of linezolid toxicity in rat models. Cite this article as: Kendir-Demirkol Y, Jenny LA, Demirkol A, Özen M, Ayata A, Canatan D. The protective effects of pyridoxine on linezolid-induced hematological toxicity, hepatotoxicity, and oxidative stress in rats. Turk Arch Pediatr. 2023;58(3):298-301.Keywords
This publication has 19 references indexed in Scilit:
- Effect of linezolid on hematological and oxidative parameters in ratsThe Journal of Antibiotics, 2014
- Severe Drug-induced Liver Injury Associated with Prolonged Use of LinezolidJournal of Medical Toxicology, 2010
- Evidence of High •OH Radical Quenching Efficiency by Vitamin B6The Journal of Physical Chemistry B, 2009
- The role of vitamin B6 in the prevention of haematological toxic effects of linezolid in patients with cancerJournal of Antimicrobial Chemotherapy, 2007
- Comparative Study of the Effects of Pyridoxine, Rifampin, and Renal Function on Hematological Adverse Events Induced by LinezolidAntimicrobial Agents and Chemotherapy, 2007
- No Effect of Pyridoxine on the Incidence of Myelosuppression during Prolonged Linezolid TreatmentClinical Infectious Diseases, 2006
- Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6Journal of Antimicrobial Chemotherapy, 2004
- Hematologic Effects of Linezolid: Summary of Clinical ExperienceAntimicrobial Agents and Chemotherapy, 2002
- [43] Malondialdehyde determination as index of lipid Peroxidation1990
- [13] Catalase in vitro1984